CRCatherine C. Robertson

Catherine C. Robertson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Catherine C. Robertson has a total of 223 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic integration reveals causal effects of chromatin accessibility on nucleosome positioning across diverse muscle cells

    by Xiaoou Wang, Catherine C. Robertson, Arushi Varshney, Nandini Manickam, Peter Orchard, Markku Laakso, Jaakko Tuomilehto, Timo A. Lakka, Karen L. Mohlke, Michael Boehnke, et al.

  • Open Access

    Genetic demultiplexing and transcript start site identification from nanopore sequencing of 10x Genomics multiome libraries

    by Joseph Mears, Peter Orchard, Arushi Varshney, Maya L Bose, Catherine C Robertson, Mary Piper, Evanthia Pashos, Vladislav Dolgachev, Nandini Manickam, Pierre Jean, et al.

    Short-read Illumina sequencing of 10x Genomics single-nucleus multiome libraries captures only the 3’ end of RNA transcripts, losing transcription start site (TSS) information. Here we demonstrate nanopore sequencing of 10x multiome libraries, which enables the profiling of full length transcripts. We show concordance with common short-read sequencing based workflows including successful genetic demultiplexing of nanopore data despite its higher error rate. We compare TSS identified using nanopore sequencing of multiome cDNA to those identified using a short-read 5’ assay, and provide an optimized approach for the preprocessing of nanopore reads prior to TSS identification. We find that nanopore sequencing of multiome cDNA captures a median of 63% of the TSS detected by the 5’ assay.

  • Open Access

    HLA-focused type 1 diabetes genetic risk prediction in populations of diverse ancestry

    by Dominika A. Michalek, Courtney Tern, Catherine C. Robertson, Wei-Min Chen, Suna Onengut-Gumuscu, Stephen S. Rich

    Aims/hypothesis: Type 1 diabetes is characterised by the destruction of pancreatic beta cells. Genetic factors account for approximately 50% of the total risk, with variants in the HLA region contributing to half of this genetic risk. Research has historically focused on populations of European ancestry. We developed HLA-focused type 1 diabetes genetic risk scores (T1D GRS HLA ) using SNPs or HLA alleles from four ancestry groups (admixed African [AFR; T1D GRS HLA-AFR ], admixed American [AMR; T1D GRS HLA-AMR ], European [EUR; T1D GRS HLA-EUR ] and Finnish [FIN; T1D GRS HLA-FIN ]). We also developed an across-ancestry GRS (ALL; T1D GRS HLA-ALL ). We assessed the performance of the GRS in each population to determine the transferability of constructed scores. Methods: A total of 41,689 samples and 13,695 SNPs in the HLA region were genotyped, with HLA alleles imputed using the HLA-TAPAS multi-ethnic reference panel. Conditionally independent SNPs and HLA alleles associated with type 1 diabetes were identified in each population group to construct T1D GRS HLA models. Generated T1D GRS HLA models were used to predict HLA-focused type 1 diabetes genetic risk across four ancestry groups. The performance of each T1D GRS HLA model was assessed using receiver operating characteristic (ROC) AUCs, and compared statistically. Results: Each T1D GRS HLA model included a different number of conditionally independent HLA-region SNPs (AFR, n =5; AMR, n =3; EUR, n =38; FIN, n =6; ALL, n =36) and HLA alleles (AFR, n =6; AMR, n =5; EUR, n =40; FIN, n =8; ALL, n =41). The ROC AUC values for the T1D GRS HLA from SNPs or HLA alleles were similar, and ranged from 0.73 (T1D GRS HLA-allele-AMR applied to FIN) to 0.88 (T1D GRS HLA-allele-EUR applied to EUR). The ROC AUC using the combined set of conditionally independent SNPs (T1D GRS HLA-SNP-ALL ) or HLA alleles (T1D GRS HLA-allele-ALL ) performed uniformly well across all ancestry groups, with values ranging from 0.82 to 0.88 for SNPs and 0.80 to 0.87 for HLA alleles. Conclusions/interpretation: T1D GRS HLA models derived from SNPs performed equivalently to those derived from HLA alleles across ancestries. In addition, T1D GRS HLA-SNP-ALL and GRS HLA-allele-ALL models had consistently high ROC AUC values when applied across ancestry groups. Larger studies in more diverse populations are needed to better assess the transferability of T1D GRS HLA across ancestries. Graphical


  • Open Access

    Genetic integration with cell-specific nucleosome positioning resolves causal relationships underlying chromatin accessibility profiles

    by Xiaoou Wang, Catherine C. Robertson, Arushi Varshney, Nandini Manickam, Peter Orchard, Markku Laakso, Jaakko Tuomilehto, Timo A. Lakka, Karen L. Mohlke, Michael Boehnke, et al.

    Cell type-specific chromatin accessibility QTL (caQTL) mapping is a promising approach to understand genetic control of chromatin landscapes and identify regulatory mechanisms underlying GWAS associations. However, current caQTL studies lack resolution and do not distinguish nucleosome-free regions (NFR) from positioned nucleosomes. Here, we leverage statistical modeling of fragment position and length to decompose ATAC-seq profiles into NFRs and phased nucleosomes. With single nucleus (sn)ATAC-seq from 281 human muscle biopsies, we map cell type-specific genetic effects on NFRs (76,027 nfrQTLs) and nucleosome occupancy (24,623 nucQTLs) across skeletal muscle cell types. Colocalization and causal inference between nucQTLs and nearby nfrQTLs and show that nfrQTLs are substantially more likely to causally influence nucQTLs and phase adjacent nucleosomes, indicating a causal relationship in shaping chromatin profiles. Hundreds of nfrQTLs colocalize with GWAS signals for muscle-related traits, including grip strength, atrial fibrillation, and fasting insulin, and the majority of colocalizing signals mapped to credible sets overlapping the corresponding nfrPeak. This approach adds mechanistic insights for how variants underlying caQTLs and GWAS signals exert their cis regulatory effects by initially modifying NFR accessibility and subsequently shaping broader chromatin landscapes, nucleosome positioning, gene expression, and ultimately higher-level traits and disease.


  • Open Access

    HLA-focused type 1 diabetes genetic risk prediction in populations of diverse ancestry

    by Dominika A Michalek, Courtney Tern, Catherine C. Robertson, Wei-Min Chen, Suna Onengut-Gumuscu, Stephen S. Rich

    Aims/hypothesis: Type 1 diabetes is characterized by the destruction of pancreatic beta cells. Genetic factors account for ~50% of the total risk, with variants in the Human Leukocyte Antigen (HLA) region contributing to half of this genetic risk, with research historically focused on populations of European ancestry. We developed HLA-focused type 1 diabetes genetic risk scores (T1D GRS HLA ) utilizing single nucleotide polymorphisms (SNPs) or HLA alleles from four ancestry groups (Admixed African (AFR; T1D GRS HLA-AFR ), Admixed American (AMR; T1D GRS HLA-AMR ), European (EUR; T1D GRS HLA-EUR ), Finnish (FIN; T1D GRS HLA-FIN ) and across ancestry (ALL; T1D GRS HLA-ALL ). We assessed the performance of genetic risk scores in each population to determine transferability of constructed scores. Methods: A total of 41,689 samples and 13,695 SNPs in the HLA region were genotyped, with HLA alleles imputed using the HLA TAPAS multi-ethnic reference panel. Conditionally independent SNPs and HLA alleles associated with type 1 diabetes were identified in each population group to construct T1D GRS HLA models. Generated T1D GRS HLA models were used to predict HLA-focused type 1 diabetes genetic risk across four ancestry groups. Performance of each T1D GRS HLA model was assessed using Receiver Operating Characteristic (ROC) Area Under the Curve (AUC) and compared statistically. Results: Each T1D GRS HLA model included a different number of conditionally independent HLA region SNPs (AFR, n = 5; AMR, n = 3; EUR, n = 38; FIN, n = 6; ALL, n = 36) and HLA alleles (AFR, n = 6; AMR, n = 5; EUR, n = 40; FIN, n = 8; ALL, n = 41). The ROC AUC values of T1D GRS HLA from SNPs or HLA alleles were similar and ranged from 0.73 (T1D GRS HLA-Allele-AMR applied to FIN) to 0.88 (T1D GRS HLA-Allele-EUR to EUR). The ROC AUC using the combined set of conditionally independent SNPs (T1D GRS HLA-SNP-ALL ) or HLA alleles (T1D GRS HLA-Allele-ALL ) performed uniformly well across all ancestry groups, ranging from 0.82 to 0.88 for SNPs, and 0.80 to 0.87 for HLA alleles. Conclusions/interpretation: T1D GRS HLA models derived from SNPs performed equivalently to those derived from HLA alleles across ancestries. In addition, T1D GRS HLA-SNP-ALL and GRS HLA-Allele-ALL models had consistently high ROC AUC values when applied across ancestry groups. Larger studies in more diverse populations are needed to better assess the transferability of T1D GRS HLA across ancestries.

  • Open Access

    Genetics of growth rate in induced pluripotent stem cells

    by Brian N. Lee, Henry J. Taylor, Filippo Cipriani, Narisu Narisu, Catherine C. Robertson, Amy J. Swift, Neelam Sinha, Tingfen Yan, Lori L. Bonnycastle, Nathan Dale, et al.

    Human induced pluripotent stem cells (iPSCs) have transformed biomedical research by enabling the generation of diverse cell types from accessible somatic tissues. However, certain fundamental biological properties, such as the genetic and epigenetic determinants of iPSC proliferation, remain poorly characterized. We measured the growth of iPSC lines derived from 602 unique donors using high-throughput time-lapse imaging, quantified proliferation through a growth Area-Under-the-Curve (gAUC) phenotype, and correlated gAUC with the gene expression and genotype of the cell lines. We identified 3,091 genes associated with gAUC, many of which are well established regulators of cell proliferation. We also found that rare deleterious variants in WDR54 were associated with reduced iPSC growth and that WDR54 was differentially expressed with respect to gAUC. Although no common variants showed a genome-wide association with gAUC, iPSC lines from monozygotic twins were highly correlated, and common genetic variation explained approximately 71-75% of the variance in iPSC growth rates. These results indicate a complex genetic architecture of iPSC growth rates, where rare, large-effect variants in important growth regulators, including WDR54 , are layered onto a highly polygenic background. These findings have important implications for the design of pooled iPSC-based studies and disease models, which may be confounded by intrinsic growth differences.


  • Open Access

    Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 h

    by Caleb M. Grenko, Henry J. Taylor, Lori L. Bonnycastle, Dongxiang Xue, Brian N. Lee, Zoe Weiss, Tingfen Yan, Amy J. Swift, Erin C. Mansell, Angela Lee, et al.

    Aims/hypothesis: Disruption of pancreatic islet function and glucose homeostasis can lead to the development of sustained hyperglycaemia, beta cell glucotoxicity and subsequently type 2 diabetes. In this study, we explored the effects of in vitro hyperglycaemic conditions on human pancreatic islet gene expression across 24 h in six pancreatic cell types: alpha; beta; gamma; delta; ductal; and acinar. We hypothesised that genes associated with hyperglycaemic conditions may be relevant to the onset and progression of diabetes. Methods: We exposed human pancreatic islets from two donors to low (2.8 mmol/l) and high (15.0 mmol/l) glucose concentrations over 24 h in vitro. To assess the transcriptome, we performed single-cell RNA-seq (scRNA-seq) at seven time points. We modelled time as both a discrete and continuous variable to determine momentary and longitudinal changes in transcription associated with islet time in culture or glucose exposure. Additionally, we integrated genomic features and genetic summary statistics to nominate candidate effector genes. For three of these genes, we functionally characterised the effect on insulin production and secretion using CRISPR interference to knock down gene expression in EndoC-βH1 cells, followed by a glucose-stimulated insulin secretion assay. Results: In the discrete time models, we identified 1344 genes associated with time and 668 genes associated with glucose exposure across all cell types and time points. In the continuous time models, we identified 1311 genes associated with time, 345 genes associated with glucose exposure and 418 genes associated with interaction effects between time and glucose across all cell types. By integrating these expression profiles with summary statistics from genetic association studies, we identified 2449 candidate effector genes for type 2 diabetes, HbA1c, random blood glucose and fasting blood glucose. Of these candidate effector genes, we showed that three (ERO1B, HNRNPA2B1 and RHOBTB3) exhibited an effect on glucose-stimulated insulin production and secretion in EndoC-βH1 cells. Conclusions/interpretation: The findings of our study provide an in-depth characterisation of the 24 h transcriptomic response of human pancreatic islets to glucose exposure at a single-cell resolution. By integrating differentially expressed genes with genetic signals for type 2 diabetes and glucose-related traits, we provide insights into the molecular mechanisms underlying glucose homeostasis. Finally, we provide functional evidence to support the role of three candidate effector genes in insulin secretion and production. Data availability: The scRNA-seq data from the 24 h glucose exposure experiment performed in this study are available in the database of Genotypes and Phenotypes (dbGap; https://www.ncbi.nlm.nih.gov/gap/) with accession no. phs001188.v3.p1. Study metadata and summary statistics for the differential expression, gene set enrichment and candidate effector gene prediction analyses are available in the Zenodo data repository (https://zenodo.org/) under accession number 11123248. The code used in this study is publicly available at https://github.com/CollinsLabBioComp/publication-islet_glucose_timecourse. Graphical


  • Open Access

    Untangling the genetics of beta cell dysfunction and death in type 1 diabetes

    by Catherine C. Robertson, Ruth M. Elgamal, Belle A. Henry-Kanarek, Peter Arvan, Shuibing Chen, Sangeeta Dhawan, Decio L. Eizirik, John S. Kaddis, Golnaz Vahedi, Stephen C.J. Parker, et al.


  • Open Access

    A multi-ancestry genome-wide association study in type 1 diabetes

    by Dominika A. Michalek, Courtney Tern, Wei Zhou, Catherine C. Robertson, Emily Farber, Paul Campolieto, Wei-Min Chen, Suna Onengut-Gumuscu, Stephen S. Rich

    Type 1 diabetes is a chronic autoimmune disease caused by destruction of the pancreatic β-cells. Genome-wide association (GWAS) and fine mapping studies associated with type 1 diabetes are mainly in European ancestry populations. We conducted a multi-ancestry GWAS to identify single nucleotide polymorphisms (SNPs) and HLA alleles associated with type 1 diabetes risk and age at onset. The Type 1 Diabetes Genetics Consortium (T1DGC) samples were genotyped using the Illumina CoreExome BeadChip array, and included families of largely European ancestry (EUR, N=3,222), unrelated individuals of African ancestry (AFR, N=891) and admixed (primarily Hispanic/Latino) ancestry (AMR, N=308). The four-digit multi-ancestry HLA reference panel (HLA-TAPAS) was used to impute HLA alleles. Logistic mixed models were used for analysis of genetic data with type 1 diabetes risk, while frailty models were used for analysis of age at onset. Seven loci were associated with type 1 diabetes at genome-wide significance (P-8 ) in the meta-analysis of the three ancestry groups: PTPN22 , HLA-DQA1 , IL2RA , RNLS , INS , IKZF4-RPS26-ERBB3 , and SH2B3 . Four loci were associated with age at onset ( PTPN22 , HLA-DQB1 , INS , and ERBB3 ). AFR and AMR meta-analysis revealed that the NRP1 locus was associated with both risk and age at onset; however, variants within NRP1 were not significantly associated with risk in those of EUR ancestry. In contrast, the PTPN22 variant rs2476601 (R620W) was significantly associated with risk only in EUR ancestry individuals. The HLA haplotype most significantly associated with risk in AFR and AMR ancestry was HLA-DRB1*03:01-DQA1*05:01-DQB1*02:01 differed from the HLA-DRB1*04:01-DQA1*03:01-DQB1*03:02 haplotype associated with risk in EUR ancestry. The HLA-DRB1*08:02-DQA1*04:01-DQB1*04:02 haplotype was “protective” in AMR ancestry while HLA-DRB1*08:01-DQA1*04:01-DQB1*04:02 (differing only at DRB1) was “risk” in EUR ancestry. The multi-ancestry GWAS enabled identification of ancestry-specific genetic variants, HLA alleles and haplotypes that are associated with type 1 diabetes risk and age at onset. Author Summary: Twin and family studies have shown that genetics play important role in development of type 1 diabetes in childhood. The majority of genetics studies of type 1 diabetes have been performed in populations of European ancestry. Here, we examine the influence of common genetic variants and HLA haplotypes in diverse ancestry samples of type 1 diabetes and earlier age at disease onset. We show that NRP1 region exhibits stronger association with type 1 diabetes risk and age at onset in non-European populations and PTPN22 differentiates the risk of type 1 diabetes between individuals of European and non-European ancestries. In addition, we identify protective DR-DQ HLA haplotype in Admixed individuals and DR-DQ HLA haplotype associated with increased risk for type 1 diabetes in European ancestry population. These findings could help improve identification of individuals at high genetic risk of type 1 diabetes and provide opportunities for delay or prevention of type 1 diabetes.


  • Open Access

    Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 hours

    by Caleb M. Grenko, Lori L. Bonnycastle, Henry J. Taylor, Tingfen Yan, Amy J. Swift, Catherine C. Robertson, Narisu Narisu, Michael R. Erdos, Francis S. Collins, D. Leland Taylor

    Disruption of pancreatic islet function and glucose homeostasis can lead to the development of sustained hyperglycemia, beta cell glucotoxicity, and ultimately type 2 diabetes (T2D). In this study, we sought to explore the effects of hyperglycemia on human pancreatic islet (HPI) gene expression by exposing HPIs from two donors to low (2.8mM) and high (15.0mM) glucose concentrations over 24 hours, assaying the transcriptome at seven time points using single-cell RNA sequencing (scRNA-seq). We modeled time as both a discrete and continuous variable to determine momentary and longitudinal changes in transcription associated with islet time in culture or glucose exposure. Across all cell types, we identified 1,528 genes associated with time, 1,185 genes associated with glucose exposure, and 845 genes associated with interaction effects between time and glucose. We clustered differentially expressed genes across cell types and found 347 modules of genes with similar expression patterns across time and glucose conditions, including two beta cell modules enriched in genes associated with T2D. Finally, by integrating genomic features from this study and genetic summary statistics for T2D and related traits, we nominate 363 candidate effector genes that may underlie genetic associations for T2D and related traits.